IDXX News and Press, IDEXX Laboratories Inc. From 10/23/22

Summary Baxter International has had a rough year or so, with shares declining far more than the market has. Some of this was justified by the company's high share price and weakening fundamentals. But given where shares are today, the firm does seem to offer some upside for i...

IDEXX Laboratories to Release 2022 Third Quarter Financial Results PR Newswire WESTBROOK, Maine , Oct. 11, 2022 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 202...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips I’m on the hunt for stocks to buy that are primed for a turnaround in the final quarter of 2022 and into 2023.  But what constitutes a turnaround? The S&P 500 is down more than 23% year-to-date thro...

Summary BAMCO’s 13F portfolio value decreased from $40.75B to $31.14B this quarter. Ron Baron increased SiteOne Landscape, ASGN, and Floor & Décor Holdings while reducing Taiwan Semi, Marriott Vacations Worldwide, and PENN Entertainment. Their top five position...

Summary Fundsmith’s 13F portfolio value decreased from $29.12B to $23.45B this quarter. They increased Mettler-Toledo while decreasing Intuit, Verisk Analytics, Ansys, and Rollins Inc. The top three positions are Microsoft, Philip Morris International, and Estee Lauder,...

Summary ResMed has done well to grow its top and bottom lines recently, but this doesn't make the company a great investment prospect. Shares look very pricey at this point in time and should warrant further downside moving forward. This is the case even with current catalysts...

On August 15, institutional investment managers with more than $100 million AUM had to disclose their positions at the end of Q2 2022. I curated a list of some high-profile hedge funds and looked into their holdings at the end of June 2022. June was a temporary bottom in the marke...

Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron WealthBuilder Fund (the “Fund”) declined 22.23% (Institutional Shares) in the period. We do not t...

Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Partners Fund (the “Fund”) declined 30.55% (Institutional Shares) in the period. Due to a combina...

IDEXX Laboratories enjoys a dominant market position in the veterinary care ecosystem. It is also establishing itself in adjacencies like livestock and water testing. The company's business has sticky, recurring revenues with strong defensibility during uncertain economic times. ...